Orchestra BioMed Holdings, Inc.
OBIO
$4.86
-$0.13-2.61%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -30.19% | -25.41% | -28.41% | -24.23% | -25.26% |
| Total Depreciation and Amortization | 11.15% | 11.34% | 9.31% | 7.32% | 3.86% |
| Total Amortization of Deferred Charges | 5,966.67% | 215.38% | 1.32% | -72.32% | -97.93% |
| Total Other Non-Cash Items | 54.99% | 39.92% | 64.98% | 84.58% | 84.82% |
| Change in Net Operating Assets | 13.28% | -251.90% | 110.90% | 76.87% | 115.56% |
| Cash from Operations | -25.50% | -33.21% | -20.51% | -9.61% | -9.33% |
| Capital Expenditure | -212.22% | -144.27% | -670.59% | -270.51% | -33.33% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -123.55% | -56.68% | -64.71% | 29.87% | 158.54% |
| Cash from Investing | -125.97% | -58.07% | -66.33% | 22.48% | 158.24% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 276.68% | 4,286.42% | 5,780.46% | 5,913.78% | 15,124.75% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -100.98% | -100.00% |
| Cash from Financing | 1,879.24% | 369.05% | 372.54% | -36.88% | -91.26% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 151.37% | -167.96% | -207.50% | -177.01% | 108.38% |